Journal article
Inhaled Reliever Therapies for Asthma
Abstract
Importance: The optimal inhaled reliever therapy for asthma remains unclear.
Objective: To compare short-acting β agonists (SABA) alone with SABA combined with inhaled corticosteroids (ICS) and with the fast-onset, long-acting β agonist formoterol combined with ICS for asthma.
Authors
Rayner DG; Ferri DM; Guyatt GH; O’Byrne PM; Brignardello-Petersen R; Foroutan F; Chipps B; Sumino K; Perry TT; Nyenhuis S
Journal
JAMA: The Journal of the American Medical Association, Vol. 333, No. 2, pp. 143–152
Publisher
American Medical Association (AMA)
Publication Date
January 14, 2025
DOI
10.1001/jama.2024.22700
ISSN
0098-7484